Treating trauma during COVID-19: Factors for adapting treatment to telehealth

This is the second in a series of two live, interactive webinar presentations (90 minutes each) which will focus on how best to deliver treatment of PTSD and trauma during the COVID-19 pandemic. Designed for intermediate practitioners, this presentation will focus on differences in treatment approach for PTSD between in-person and telehealth delivery, address assessment and treatment concerns related to symptom changes associated with environmental stressors (including COVID-19), and consider the impact on treatment as quarantine and stay-at-home orders are relaxed. Ample time will be allotte...Read mored at the end of the presentation to address audience questions. Less...

Register for this Webinar
After registering, you will receive a confirmation email from CE-Go (support@ceactivities.com), not Rogers. Please be sure to check your junk/spam folder for this email.

Learning Objectives

  • Identify at least three advantages to telehealth delivery of PTSD treatment.
  • Describe two ways to manage the needs of patients with various comorbid psychiatric disorders while implementing prolonged exposure (PE) via telehealth.
  • Explain one inter- and one intra-state stressor that drives changes in treatment of PTSD due to implementation and relaxation of stay-at-home/quarantine orders in response to COVID-19.

Learning Levels

  • Intermediate

Thursday, May 21, 2020

Live Interactive Webinar

01:00 PM EDT - 02:30 PM EDT

Register for this Webinar
After registering, you will receive a confirmation email from CE-Go (support@ceactivities.com), not Rogers. Please be sure to check your junk/spam folder for this email.
EARN 1.5 CE Credit Hours
After registering, you will receive a confirmation email from CE-Go (support@ceactivities.com), not Rogers. Please be sure to check your junk/spam folder for this email.

About the speakers

Loren Post, PhD

Loren Post, PhD

Clinical Director, Atlanta
Loren Post, PhD, is a licensed clinical psychologist and serves as clinical director of Rogers Behavioral Health in Atlanta. Dr. Post specializes in evidence-based cognitive-behavioral treatments for posttraumatic stress disorder (PTSD) and anxiety disorders. Her research has focused on transdiagnostic processes between PTSD and co-occurring disorders and biopsychosocial and treatment factors influencing the effectiveness of evidence-based PTSD treatment.
Joshua Nadeau, PhD

Joshua Nadeau, PhD

Senior Clinical Director
Dr. Nadeau is a licensed clinical psychologist and Senior Clinical Director with Rogers Behavioral Health. In this role, Dr. Nadeau provides support to Rogers’ outpatient clinics located across the country. In his research and practice, Dr. Nadeau focuses on the use of cognitive behavioral therapy for the treatment of obsessive-compulsive and related disorders, as well as in the adaptation of evidence-based techniques to address the unique needs of youth and adults with autism spectrum disorder (ASD) and other neurodevelopmental disorders.

Dr. Nadeau received his doctorate in school psychology and completed his post-doctoral research fellowship in clinical psychology from USF. He has authored and co-authored numerous peer-reviewed articles and book chapters on treatment of obsessive-compulsive and related disorders among children, adolescents and adults. Additionally, Dr. Nadeau is an active member of the International OCD Foundation, Association for Cognitive and Behavioral Therapies, Collaborative Family Healthcare Association, and the Association for Positive Behavioral Support.

CE Information - Earn 1.5 CE Credit Hours

CE Approvals

American Psychological Association
Rogers Behavioral Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Rogers Behavioral Health maintains responsibility for this program and its content. Rogers Behavioral Health designates this live program for X continuing education credits; no partial credits will be awarded.
Association of Social Work Boards
Rogers Behavioral Health, provider number 1101, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB), www.aswb.org, through the Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory board have the final authority to determine whether an individual course may be accepted for continuing education credit. Rogers Behavioral Health maintains responsibility for this course. Approval period: October 18, 2023 – October 18, 2026. Social workers completing this course receive X clinical continuing education credits.
National Board for Certified Counselors
Rogers Behavioral Health has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6192. Programs that do not qualify for NBCC credit are clearly identified. Rogers Behavioral Health is solely responsible for all aspects of the programs. X instructional clock hours will be awarded.
Other Professionals
Rogers Behavioral Health will issue a certificate of attendance for your participation in this activity.

CE Process Info

A Contuing Education Certificate for this program will be obtained usingthe website CE Go. After the event, you will receive an email with a link to CE Go. This link will be emailed to the account you used to register for this event.

Upon accessing the CE-Go website, you will be able to:

  • Complete the mandatory evaluation form
  • Download your CE Certificate in PDF form

Please Note: To receive CE credit, you must be logged into the webinar for the entire program; partial credit is not available.


AGENDA

1 pm ET Welcome and speaker introductions

1:05 pm Evidence-based PTSD treatment via telehealth

                     • Feasibility and effectiveness

                     • Dropout, compliance, patient preferences

                     • Prolonged exposure in person vs. telehealth

1:25 pm PTSD and co-occurring disorders

                     • Increased severity of PTSD transdiagnostic symptoms in response to COVID-19 concerns

                     • Normalizing concerns and reactions while setting expectations for symptom improvement in response to PE

                     • Managing co-occurring disorders and life stressors throughout PE treatment 

1:50 pm Virtual PE for PTSD context and clinical considerations

                     • Conducting virtual imaginal exposures

                     • In vivo exposures during social distancing with special attention to safety behaviors

                     • Pros and cons of both current telehealth and future return to the clinic

2:15 pm Moderated Q&A

2:30 pm Where to get additional information on this topic